C. Barone

467 total citations
28 papers, 287 citations indexed

About

C. Barone is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, C. Barone has authored 28 papers receiving a total of 287 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 7 papers in Surgery. Recurrent topics in C. Barone's work include Colorectal Cancer Treatments and Studies (11 papers), Lung Cancer Treatments and Mutations (9 papers) and Gastric Cancer Management and Outcomes (6 papers). C. Barone is often cited by papers focused on Colorectal Cancer Treatments and Studies (11 papers), Lung Cancer Treatments and Mutations (9 papers) and Gastric Cancer Management and Outcomes (6 papers). C. Barone collaborates with scholars based in Italy, United States and Germany. C. Barone's co-authors include J. Załuski, R. Bugat, В. А. Горбунова, Carmelo Pozzo, Vahur Valvere, Johannes Bükki, Christian Jacques, Christian Peschel, M. Biakhov and J. Szántó and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

C. Barone

26 papers receiving 280 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. Barone Italy	8	203	177	106	51	35	28	287
Ann Tan United States	7	61 0.3×	98 0.6×	95 0.9×	29 0.6×	50 1.4×	16	235
Nikhil Pande India	10	132 0.7×	134 0.8×	54 0.5×	33 0.6×	47 1.3×	30	227
Yongqiang Xie China	6	129 0.6×	83 0.5×	170 1.6×	96 1.9×	7 0.2×	8	280
Yasunari Ubukata Japan	9	92 0.5×	105 0.6×	81 0.8×	46 0.9×	5 0.1×	33	220
Justin K. Smit Netherlands	14	346 1.7×	97 0.5×	384 3.6×	86 1.7×	9 0.3×	21	490
Nadim Bashir United Kingdom	5	233 1.1×	106 0.6×	232 2.2×	21 0.4×	5 0.1×	5	316
Nicolas Briez France	9	626 3.1×	116 0.7×	671 6.3×	75 1.5×	10 0.3×	10	799
Diana C. Medgyesy United States	7	122 0.6×	257 1.5×	47 0.4×	51 1.0×	3 0.1×	11	305
Fu-Zhi Ji China	9	195 1.0×	57 0.3×	113 1.1×	120 2.4×	6 0.2×	12	384
Akesu Sujie China	8	90 0.4×	114 0.6×	79 0.7×	35 0.7×	3 0.1×	17	180

Countries citing papers authored by C. Barone

Since Specialization

Citations

This map shows the geographic impact of C. Barone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Barone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Barone more than expected).

Fields of papers citing papers by C. Barone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Barone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Barone. The network helps show where C. Barone may publish in the future.

Co-authorship network of co-authors of C. Barone

This figure shows the co-authorship network connecting the top 25 collaborators of C. Barone. A scholar is included among the top collaborators of C. Barone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Barone. C. Barone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Martinello, Rossella, Patrizia Vici, Mario Airoldi, et al.. (2019). Trastuzumab‐related cardiotoxicity in patients with nonlimiting cardiac comorbidity. The Breast Journal. 25(3). 444–449. 4 indexed citations

2.

Schena, Marina, Sara Bustreo, C. Barone, et al.. (2012). Neoadjuvant chemo-radiotherapy for locally advanced esophageal cancer: a monocentric study.. PubMed. 98(4). 451–7. 5 indexed citations

3.

Schena, Marina, Sara Bustreo, C. Barone, et al.. (2012). Neoadjuvant chemo-radiotherapy for locally advanced esophageal cancer: A monocentric study. Tumori Journal. 98(4). 451–457. 5 indexed citations

4.

Aglietta, Massimo, C. Barone, Malcolm J. Moore, et al.. (2011). Final toxicity results of a phase I dose-escalation trial of tremelimumab (CP-675206) in combination with gemcitabine in chemotherapy-naive patients (pts) with metastatic pancreatic cancer.. Journal of Clinical Oncology. 29(15_suppl). 4081–4081. 4 indexed citations

5.

Rampino, Monica, Umberto Ricardi, C. Barone, et al.. (2010). Concomitant Adjuvant Chemoradiotherapy with Weekly Low-dose Cisplatin for High-risk Squamous Cell Carcinoma of the Head and Neck: a Phase II Prospective Trial. Clinical Oncology. 23(2). 134–140. 33 indexed citations

6.

Aglietta, Massimo, C. Barone, Cinzia Bagalá, et al.. (2010). A phase I dose escalation trial of CP-675206 (tremelimumab) in combination with gemcitabine in patients with chemotherapy-naive metastatic pancreatic cancer.. Journal of Clinical Oncology. 28(15_suppl). 4134–4134. 5 indexed citations

7.

Laffranchi, B., Maja J. De Jonge, E. Bajetta, et al.. (2010). Phase II study of danusertib (D) in advanced/metastatic colorectal and pancreatic cancers (CRC, PC).. Journal of Clinical Oncology. 28(15_suppl). e13558–e13558. 6 indexed citations

8.

Caponigro, Francesco, Domenica Lorusso, C. Barone, et al.. (2009). Phase I dose-escalation study of brostallicin, a minor groove binder, in combination with cisplatin in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 66(2). 389–394. 6 indexed citations

9.

Mutri, V., S. Giaquinta, Francesca Di Fabio, et al.. (2009). 6656 Evaluation of sE-Selectin and circulating Vascular Endothelial Growth Factor (VEGF) in patients with advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma treated with cetuximab in combination with cisplatin and docetaxel (Italian phase II DOCETUX Study). European Journal of Cancer Supplements. 7(2). 405–405. 1 indexed citations

10.

Pinto, Carmine, Francesca Di Fabio, C. Barone, et al.. (2008). Cetuximab in combination with cisplatin and docetaxel as first-line treatment in patients with locally advanced or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma (Italian phase II DOCETUX study). Journal of Clinical Oncology. 26(15_suppl). 4575–4575. 8 indexed citations

11.

Daniele, Lorenzo, C. Barone, Anna Sapino, et al.. (2008). Gefitinib (ZD1839): Therapy in selected patients with non-small cell lung cancer (NSCLC)?. Lung Cancer. 61(1). 73–81. 21 indexed citations

12.

Buffoni, L, C. Barone, Davide Ottaviani, et al.. (2006). Fractionated dose of cisplatin (CDDP) and vinorelbine (VNB) chemotherapy for elderly patients with advanced non-small cell lung cancer: Phase II trial. Lung Cancer. 54(3). 353–357. 6 indexed citations

13.

Novello, Silvia, Paolo Bruzzi, C. Barone, et al.. (2005). Phase III study in stage IV non-small-cell lung cancer (NSCLC) patients (pts) treated with two cycles of cisplatin/gemcitabine followed by a randomization to three additional cycles of the same combination or gemcitabine alone. Journal of Clinical Oncology. 23(16_suppl). 7051–7051. 3 indexed citations

14.

Buffoni, L, et al.. (2005). Second-line chemotherapy with weekly paclitaxel and gemcitabine in patients with small-cell lung cancer pretreated with platinum and etoposide: a single institution phase II trial. Cancer Chemotherapy and Pharmacology. 58(2). 203–209. 11 indexed citations

15.

Pozzo, Carmelo, C. Barone, J. Szántó, et al.. (2004). Irinotecan in combination with 5-fluorouracil and folinic acid or with cisplatin in patients with advanced gastric or esophageal-gastric junction adenocarcinoma: results of a randomized phase II study. Annals of Oncology. 15(12). 1773–1781. 126 indexed citations

16.

Schena, M, C. Barone, Nadia Birocco, et al.. (2004). Weekly cisplatin paclitaxel and continuous infusion fluorouracil in patients with recurrent and/or metastatic head and neck squamous cell carcinoma: a phase II study. Cancer Chemotherapy and Pharmacology. 55(3). 271–276. 10 indexed citations

17.

Berruti, Alfredo, L Buffoni, Alfredo Addeo, et al.. (2004). Sequential chemotherapy of cisplatin and vinorelbine followed by paclitaxel and gemcitabine in advanced non-small-cell lung cancer. Lung Cancer. 47(2). 269–275. 9 indexed citations

18.

Buffoni, L, et al.. (2004). Second-line chemotherapy with weekly paclitaxel and gemcitabine in platinum-etoposide pretreated patients with small cell lung cancer (SCLC): A single institution phase II trial. Journal of Clinical Oncology. 22(14_suppl). 7209–7209. 1 indexed citations

19.

Buffoni, L, et al.. (2004). Second-line chemotherapy with weekly paclitaxel and gemcitabine in platinum-etoposide pretreated patients with small cell lung cancer (SCLC): A single institution phase II trial. Journal of Clinical Oncology. 22(14_suppl). 7209–7209. 2 indexed citations

20.

Cassano, Alessandra, Carmelo Pozzo, Lucia Angelelli, et al.. (1999). Weekly gemcitabine (GEM) and 5-fluorouracil (5-FU) in pancreatic carcinoma. Phase I–II study. European Journal of Cancer. 35. S156–S156. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact